CRANBURY, N.J., Aug. 8, 2016 /PRNewswire/ -- Palatin
Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company
developing targeted, receptor-specific peptide therapeutics for the
treatment of diseases with significant unmet medical need and
commercial potential, announced today that Carl Spana, the Company's President & Chief
Executive Officer, will present at the 36th Annual
Canaccord Genuity Growth Conference on Thursday, August 11th, 2016 at
1:00 p.m. Eastern time. The
conference is being held at the InterContinental Boston,
Boston, MA August 10-11, 2016.
About Palatin Technologies
Palatin Technologies, Inc.
is a biopharmaceutical company developing targeted,
receptor-specific peptide therapeutics for the treatment of
diseases with significant unmet medical need and commercial
potential. Palatin's strategy is to develop products and then form
marketing collaborations with industry leaders in order to maximize
their commercial potential. For additional information regarding
Palatin, please visit Palatin's website at
http://www.palatin.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/palatin-technologies-to-present-at-the-36th-annual-canaccord-genuity-growth-conference-300310390.html
SOURCE Palatin Technologies, Inc.